During a study designed to determine if systemic MBNL2 overexpression in neonatal mice would block disease progression in the HSALR polyCUG model of DM1, we also tested for nonspecific effects of an unrelated RBP, HNRNPA1. Here, HNRNPA1 is linked to myotonic dystrophy type 1.